{"id":15795,"date":"2021-10-29T16:56:13","date_gmt":"2021-10-29T20:56:13","guid":{"rendered":"https:\/\/arsacs.com\/?p=15795"},"modified":"2026-03-16T18:13:39","modified_gmt":"2026-03-16T22:13:39","slug":"exploring-the-role-of-genetic-and-epigenetic-modifiers-in-modifiers-in-arsacs-dr-daniele-galatolo","status":"publish","type":"post","link":"https:\/\/arsacs.com\/fr\/exploring-the-role-of-genetic-and-epigenetic-modifiers-in-modifiers-in-arsacs-dr-daniele-galatolo\/","title":{"rendered":"\u201cExploring the role of genetic and epigenetic modifiers in modifiers in ARSACS\u201d &#8211; Dr. Daniele Galatolo"},"content":{"rendered":"<p>The overall aim of this research is to identify the potential co-occurrence of genomic variants beyond mutations in the&nbsp;<em>SACS<\/em> gene, and the epigenetic effects that might explain the different phenotype severity existing among ARSACS patients.&nbsp;<\/p>\n<p>Grant : $52,000<\/p>\n<p>Dur\u00e9e : un an&nbsp;<\/p>\n<p>Contact :<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-15770 alignleft\" src=\"https:\/\/arsacs.com\/wp-content\/uploads\/2021\/10\/Daniele-Galatolo-photo-201x300.jpg\" alt=\"\" width=\"155\" height=\"231\" srcset=\"https:\/\/arsacs.com\/wp-content\/uploads\/2021\/10\/Daniele-Galatolo-photo-201x300.jpg 201w, https:\/\/arsacs.com\/wp-content\/uploads\/2021\/10\/Daniele-Galatolo-photo.jpg 408w\" sizes=\"(max-width: 155px) 100vw, 155px\" \/><\/p>\n<p>Dr. Daniele Galatolo<\/p>\n<p>Molecular Medicine for Neurodegenerative and Neuromuscular Diseases Unit<\/p>\n<p>IRCCS Stella Maris Foundation<br>via dei Giacinti 2,<\/p>\n<p>56128 Calambrone (Pisa) - Italy<\/p>\n<p>Email : daniele.galatolo@fsm.unipi.it<\/p>\n\n\n<p class=\"wp-block-paragraph\"><\/p>","protected":false},"excerpt":{"rendered":"<p>The overall aim of this research is to identify the potential co-occurrence of genomic variants beyond mutations in the&nbsp;SACS gene, and the epigenetic effects that might explain the different phenotype severity existing among ARSACS patients.&nbsp; Grant : $52,000 Duration : one year&nbsp; Contact: Dr. Daniele Galatolo Molecular Medicine for Neurodegenerative and Neuromuscular Diseases Unit IRCCS [&#8230;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[85],"tags":[],"class_list":["post-15795","post","type-post","status-publish","format-standard","hentry","category-recherche-2021"],"_links":{"self":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts\/15795","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/comments?post=15795"}],"version-history":[{"count":5,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts\/15795\/revisions"}],"predecessor-version":[{"id":24756,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts\/15795\/revisions\/24756"}],"wp:attachment":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/media?parent=15795"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/categories?post=15795"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/tags?post=15795"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}